1). Magadur-Joly G., Billaud E., Barrier JH., Pennec YL., Masson C., Renou P, et al. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis. 1995. 54:587–90.
Article
2). Efthimiou P., Paik PK., Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis. 2006. 65:564–72.
Article
3). Park JH., Bae JH., Choi YS., Lee HS., Jun JB., Jung S, et al. Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A. J Korean Med Sci. 2004. 19:137–41.
Article
4). Yamaguchi M., Ohta A., Tsunematsu T., Kasukawa R., Mizushima Y., Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992. 19:424–30.
5). Kumakura S., Ishikura H., Umegae N., Yamagata S., Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Am J Med. 1997. 102:113–5.
Article
6). Amenomori M., Migita K., Miyashita T., Yoshida S., Ito M., Eguchi K, et al. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease. Clin Exp Rheumatol. 2005. 23:100–2.
7). Egeler RM., Shapiro R., Loechelt B., Filipovich A. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 1996. 18:340–5.
Article
8). Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum. 2004. 50:689–98.
Article
9). Dhote R., Simon J., Papo T., Detournay B., Sailler L., Andre MH, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003. 49:633–9.
Article
10). Kumakura S., Ishikura H., Munemasa S., Adachi T., Murakawa Y., Kobayashi S. Adult onset Still's disease associated hemophagocytosis. J Rheumatol. 1997. 24:1645–8.
11). Arlet JB., Le TH., Marinho A., Amoura Z., Wechsler B., Papo T, et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006. 65:1596–601.
Article
12). Fautrel B., Sibilia J., Mariette X., Combe B. Club Rhumatismes et Inflammation. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis. 2005. 64:262–6.
13). Kokkinos A., Iliopoulos A., Greka P., Efthymiou A., Katsilambros N., Sfikakis PP. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol. 2004. 23:45–9.
Article
14). Emmenegger U., Frey U., Reimers A., Fux C., Semela D., Cottagnoud P, et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol. 2001. 68:4–10.
Article